Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis

References

• Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1962;25:315–20.
   PubMed Web of Science ®Google Scholar
• Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain. 2005;128:2705–12.
   PubMed Web of Science ®Google Scholar
• Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain. 1999;122(Pt 1):17–26.
   PubMedGoogle Scholar
• Geurts JJ, Bo L, Pouwels PJ, Castelijns JA, Polman CH, Barkhof F. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol. 2005;26:572–7.
   PubMed Web of Science ®Google Scholar
• Bjartmar C, Battistuta J, Terada N, Dupree E, Trapp BD. N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve. Ann Neurol. 2002;51:51–8.
   PubMed Web of Science ®Google Scholar
• De Stefano N, Narayanan S, Francis GS, Arnaoutelis R, Tartaglia MC, Antel JP. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol. 2001;58:65–70.
   PubMed Web of Science ®Google Scholar
• Adalsteinsson E, Langer-Gould A, Homer RJ, Rao A, Sullivan EV, Lima CA. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol. 2003;24:1941–1945.
   PubMed Web of Science ®Google Scholar
• Chard DT, Griffin CM, McLean MA, Kapeller P, Kapoor R, Thompson AJ, et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain. 2002;125:2342–52.
   PubMed Web of Science ®Google Scholar
• Fu L, Matthews PM, De Stefano N, Worsley KJ, Narayanan S, Francis GS, et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain. 1998;121(Pt 1):103–13.
   PubMedGoogle Scholar
• Kapeller P, McLean MA, Griffin CM, Chard D, Parker GJ, Barker GJ, et al. Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study. J Neurol. 2001;248:131–8.
   PubMed Web of Science ®Google Scholar
• He J, Inglese M, Li BS, Babb JS, Grossman RI, Gonen O. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience. Radiology. 2005;234:211–7.
   PubMed Web of Science ®Google Scholar
• De Stefano N, Matthews PM, Antel JP, Preul M, Francis G, Arnold DL. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol. 1995;38:901–9.
   PubMed Web of Science ®Google Scholar
• De Stefano N, Matthews PM, Fu L, Narayanan S, Stanley J, Francis GS, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain. 1998;121(Pt 8):1469–77.
   PubMed Web of Science ®Google Scholar
• Wattjes MP, Harzheim M, Lutterbey GG, Bogdanow M, Schild HH, Träber F. High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria. J Neurol. 2008;255:56–63.
   PubMed Web of Science ®Google Scholar
• Tiberio M, Chard DT, Altmann DR, Davies G, Griffin CM, McLean MA, et al. Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study. J Neurol. 2006;253:224–30.
   PubMed Web of Science ®Google Scholar
• Staffen W, Zauner H, Mair A, Kutzelnigg A, Kapeller P, Stangl H, et al. Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis. J Neuropsychiatry Clin Neurosci. 2005;17:357–63.
   PubMed Web of Science ®Google Scholar
• Sharma R, Narayana PA, Wolinsky JS. Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging. Mult Scler. 2001;7:221–6.
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Presciutti O, Tarducci R, Gobbi G, Alberti A, Pelliccioli GP, et al. Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis. J Neurol. 2002;249:902–10.
   PubMed Web of Science ®Google Scholar
• Geurts JJ, Reuling IE, Vrenken H, Uitdehaag BM, Polman CH, Castelijns JA, et al. MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis. Magn Reson Med. 2006;55:478–83.
   PubMed Web of Science ®Google Scholar
• Sijens PE, Mostert JP, Oudkerk M, De Keyser J. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings. Eur Radiol. 2006;16:489–95.
   PubMed Web of Science ®Google Scholar
• Caramanos Z, DiMaio S, Narayanan S, Lapierre Y, Arnold DL. (1)H-MRSI evidence for cortical gray matter pathology that is independent of cerebral white matter lesion load in patients with secondary progressive multiple sclerosis. J Neurol Sci. 2009;282:72–9.
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–52.
   PubMed Web of Science ®Google Scholar
• Mathiesen HK, Tscherning T, Sorensen PS, Larsson HB, Rostrup E, Paulson OB, et al. Multi-slice echo-planar spectroscopic MR imaging provides both global and local metabolite measures in multiple sclerosis. Magn Reson Med. 2005;53:750–9.
   PubMed Web of Science ®Google Scholar
• Mathiesen HK, Jonsson A, Tscherning T, Hanson LG, Andresen J, Blinkenberg M, et al. Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis. Arch Neurol. 2006;63:533–6.
   PubMedGoogle Scholar
• Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479–89.
   PubMed Web of Science ®Google Scholar
• Hill DL, Maurer CR Jr, Studholme C, Fitzpatrick JM, Hawkes DJ. Correcting scaling errors in tomographic images using a nine degree of freedom registration algorithm. J Comput Assist Tomogr. 1998;22:317–23.
   PubMed Web of Science ®Google Scholar
• Rigotti DJ, Inglese M, Kirov II, Gorynski E, Perry NN, Babb JS, et al. Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis. Neurology. 2012;78:1383–9.
   PubMed Web of Science ®Google Scholar
• Posse S, DeCarli C, Le Bihan D. Three-dimensional echo-planar MR spectroscopic imaging at short echo times in the human brain. Radiology. 1994;192:733–8.
   PubMed Web of Science ®Google Scholar
• Lim KO, Adalsteinsson E, Spielman D, Sullivan EV, Rosenbloom MJ, Pfefferbaum A. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry. 1998;55:346–52.
   PubMed Web of Science ®Google Scholar
• Brenner RE, Munro PM, Williams SC, Bell JD, Barker GJ, Hawkins CP, et al. The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med. 1993;29:737–45.
   PubMed Web of Science ®Google Scholar
• Gustafsson MC, Dahlqvist O, Jaworski J, Lundberg P, Landtblom AM. Low choline concentrations in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans. AJNR Am J Neuroradiol. 2007;28:1306–12.
   PubMed Web of Science ®Google Scholar
• Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol. 2006;5:158–70.
   PubMed Web of Science ®Google Scholar
• Gauthier SA, Mandel M, Guttmann CR, Glanz BI, Khoury SJ, Betensky RA, et al. Predicting short-term disability in multiple sclerosis. Neurology. 2007;68:2059–65.
   PubMed Web of Science ®Google Scholar